RBC Life Science and Technology Sr A (RBF274)
59.23
+0.65
(+1.11%)
CAD |
Apr 01 2026
RBF274 Asset Allocations & Exposures
Asset Allocation
As of February 28, 2026.
| Type | % Net |
|---|---|
| Cash | 1.51% |
| Stock | 98.11% |
| Bond | 0.39% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.00% |
Market Capitalization
As of February 28, 2026
| Large | 89.83% |
| Mid | 6.86% |
| Small | 3.32% |
Region Exposure
| Americas | 95.90% |
|---|---|
|
North America
|
95.19% |
| Canada | 2.12% |
| United States | 93.07% |
|
Latin America
|
0.71% |
As of February 28, 2026. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 3.33% |
|---|---|
| United Kingdom | 0.48% |
|
Europe Developed
|
2.85% |
| Belgium | 0.42% |
| Ireland | 1.49% |
| Netherlands | 0.94% |
| Switzerland | 0.00% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| United Arab Emirates | 0.00% |
| Greater Asia | 0.65% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
| Australia | 0.00% |
|
Asia Developed
|
0.50% |
| Singapore | 0.00% |
| Taiwan | 0.49% |
|
Asia Emerging
|
0.15% |
| China | 0.15% |
| Unidentified Region | 0.12% |
|---|
Stock Sector Exposure
| Cyclical |
|
1.95% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.77% |
| Financials |
|
0.74% |
| Real Estate |
|
0.44% |
| Sensitive |
|
78.26% |
| Communication Services |
|
19.65% |
| Energy |
|
0.00% |
| Industrials |
|
1.15% |
| Information Technology |
|
57.46% |
| Defensive |
|
19.78% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
19.78% |
| Utilities |
|
0.00% |
| Not Classified |
|
0.01% |
| Non Classified Equity |
|
0.00% |
| Not Classified - Non Equity |
|
0.01% |
As of February 28, 2026
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |